The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Human resources software startup Factorial has raised $150 million in funding at a valuation of $2.5 billion, making it one of the most highly valued startups in Spain. The Series D funding round was ...

As Billerica battery company Factorial cruises into the public markets this week, it will have a veteran driver at its side: “Dr. Z.” Dieter Zetsche, one of the best-known executives in the car ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Founded in the greater Boston area, Factorial develops solid-state batteries. Credit: Noah Emad / Shutterstock.com US solid-state battery developer Factorial Energy has begun trading on the Nasdaq ...

General Catalyst leads $150M equity investment, its first equity stake in Factorial as part of Series D round that values the company at over $2.5 billion, becoming one of the most valuable AI ...

BARCELONA—Factorial closed a $150 million funding round that lifted its valuation to $2.5 billion, bringing in fresh capital to expand as artificial intelligence reshapes the business-management ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company is backed by ...

Factorial Energy Inc. (NASDAQ: FAC) is in focus today, a day after making its Nasdaq debut following the completion of its SPAC merger with Cartesian Growth Corporation III. Factorial is a ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...